In the last trading session, U.S. stocks were slightly in the green. Investors were probably clueless about the growth momentum of the U.S. economy as manufacturing data for the month of August came in soft suddenly. Among the top ETFs, investors saw SPY gain about 0.01%, DIA add about 0.1% and QQQ advance about 0.3% on the day.
Two more specialized ETFs are worth noting in particular though as both saw trading volume that was far outside of normal. In fact, in the most recent trading session, both these funds experienced volume levels that were more than double their average. This could make these ETFs the ones to watch out for in the days ahead to see if this trend of extra interest continues:
FXH: Volume 3.72 times average
This healthcare ETF was under the microscope on Thursday as nearly 532,666 shares moved hands. This compares to an average trading volume of 143,220 shares and came as FXH lost about 0.2% in the session.
The movement can be credited to ongoing issues over the pricing of drugs. In the last one-month period, FXH was down over 1.6%. The fund has a Zacks ETF Rank #2 (Buy).
DVP: Volume 2.95 times average
This value ETF was in focus yesterday as roughly 18,000 shares moved hands compared with an average of roughly 6,000 shares. DVP lost about 0.1% on the day. However, in the last one-month period, DVP was up 1.8%. The fund has a Zacks ETF Rank #3 (Hold).
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
In the last trading session, U.S. stocks were slightly in the green. Investors were probably clueless about the growth momentum of the U.S. economy as manufacturing data for the month of August came in soft suddenly. Among the top ETFs, investors saw SPY gain about 0.01%, DIA add about 0.1% and QQQ advance about 0.3% on the day.
Two more specialized ETFs are worth noting in particular though as both saw trading volume that was far outside of normal. In fact, in the most recent trading session, both these funds experienced volume levels that were more than double their average. This could make these ETFs the ones to watch out for in the days ahead to see if this trend of extra interest continues:
FXH: Volume 3.72 times average
This healthcare ETF was under the microscope on Thursday as nearly 532,666 shares moved hands. This compares to an average trading volume of 143,220 shares and came as FXH lost about 0.2% in the session.
The movement can be credited to ongoing issues over the pricing of drugs. In the last one-month period, FXH was down over 1.6%. The fund has a Zacks ETF Rank #2 (Buy).
DVP: Volume 2.95 times average
This value ETF was in focus yesterday as roughly 18,000 shares moved hands compared with an average of roughly 6,000 shares. DVP lost about 0.1% on the day. However, in the last one-month period, DVP was up 1.8%. The fund has a Zacks ETF Rank #3 (Hold).
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on QQQ - FREE
Get the latest research report on SPY - FREE
Get the latest research report on DIA - FREE
Get the latest research report on FXH - FREE